Related references
Note: Only part of the references are listed.Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction
Jaqueline S. da Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers
Christian David Hernandez-Silva et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
G Protein-Coupled Estrogen Receptor in Immune Cells and Its Role in Immune-Related Diseases
George Notas et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies
Laura Ondrisova et al.
FRONTIERS IN ONCOLOGY (2020)
G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis
Damian Jacenik et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)
Preetesh Jain et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma
Jia Ruan et al.
BLOOD (2018)
Aberrant Activation of NF-kappa B Signalling in Aggressive Lymphoid Malignancies
Ruth Kennedy et al.
CELLS (2018)
Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
Qiao Liu et al.
MOLECULAR CANCER (2017)
Estrogens Promote the Production of Natural Neutralizing Antibodies in Fish through G Protein-Coupled Estrogen Receptor 1
Maria C. Rodenas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mitochondria, Bioenergetics and Apoptosis in Cancer
Peter J. Burke
TRENDS IN CANCER (2017)
The potential for chemotherapy-free strategies in mantle cell lymphoma
Peter Martin et al.
BLOOD (2017)
Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals
Shuwei Liang et al.
CANCER LETTERS (2017)
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
Vasiliki Pelekanou et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Postibrutinib outcomes in patients with mantle cell lymphoma
Peter Martin et al.
BLOOD (2016)
Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals
Guangfa Zhu et al.
DNA AND CELL BIOLOGY (2016)
Obligatory role for GPER in cardiovascular aging and disease
Matthias R. Meyer et al.
SCIENCE SIGNALING (2016)
Obligatory role for GPER in cardiovascular aging and disease
Matthias R. Meyer et al.
SCIENCE SIGNALING (2016)
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes
C. Y. Cheah et al.
ANNALS OF ONCOLOGY (2015)
The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells
Martina Rudelius et al.
HAEMATOLOGICA (2015)
What have we learned about GPER function in physiology and disease from knockout mice?
Eric R. Prossnitz et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
Adele Chimento et al.
ONCOTARGET (2015)
The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells
Martina Rudelius et al.
HAEMATOLOGICA (2015)
Mantle cell lymphoma: evolving management strategies
Elias Campo et al.
BLOOD (2015)
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study
Anna Abrahamsson et al.
BLOOD (2014)
Nox family NADPH oxidases: Molecular mechanisms of activation
Ralf P. Brandes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
A dynamic network of estrogen receptors in murine lymphocytes: fine-tuning the immune response
Andrea E. Schneider et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast
Allison L. Scaling et al.
HORMONES & CANCER (2014)
Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France
Alain Monnereau et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Silvia Bea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization
C. Wang et al.
CELL DEATH & DISEASE (2013)
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
Satoe Fujiwara et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Patricia Perez-Galan et al.
BLOOD (2011)
Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1
Ryan L. Brunsing et al.
IMMUNOLOGY (2011)
Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo
K. Yakimchuk et al.
LEUKEMIA (2011)
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
Davide Gianni et al.
ACS CHEMICAL BIOLOGY (2010)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest
Q. K. Y. Chan et al.
CELL DEATH AND DIFFERENTIATION (2010)
GPR30 predicts poor survival for ovarian cancer
Harriet O. Smith et al.
GYNECOLOGIC ONCOLOGY (2009)
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines
Jordi Camps et al.
LEUKEMIA RESEARCH (2006)
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa et al.
NATURE CHEMICAL BIOLOGY (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
DNA damage-induced apoptosis
CJ Norbury et al.
ONCOGENE (2004)
Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519
C Rudolph et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
A Sancar et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Share Paper
